References analysis of the Wikipedia article "Receptor 5-HT3" in the Spanish version

doi.org

dx.doi.org

Barnes NM, Hales TG, Lummis SC, Peters JA (January 2009). «The 5-HT3 receptor--the relationship between structure and function». Neuropharmacology 56 (1): 273-284. PMC 6485434. PMID 18761359. doi:10.1016/j.neuropharm.2008.08.003.

Thompson AJ, Lummis SC (2006). «5-HT3 Receptors». Current Pharmaceutical Design 12 (28): 3615-3630. PMC 2664614. PMID 17073663. doi:10.2174/138161206778522029.

Reeves DC, Lummis SC (2002). «The molecular basis of the structure and function of the 5-HT3 receptor: a model ligand-gated ion channel (review)». Molecular Membrane Biology 19 (1): 11-26. PMID 11989819. doi:10.1080/09687680110110048.

Davies PA, Pistis M, Hanna MC, Peters JA, Lambert JJ, Hales TG, Kirkness EF (1999). «The 5-HT_3B subunit is a major determinant of serotonin-receptor function». Nature 397 (6717): 359-363. Bibcode:1999Natur.397..359D. PMID 9950429. doi:10.1038/16941.

Dubin AE, Huvar R, D'Andrea MR, Pyati J, Zhu JY, Joy KC, Wilson SJ, Galindo JE, Glass CA, Luo L, Jackson MR, Lovenberg TW, Erlander MG (1999). «The pharmacological and functional characteristics of the serotonin 5-HT_3A receptor are specifically modified by a 5-HT_3B receptor subunit». J Biol Chem 274 (43): 30799-30810. PMID 10521471. doi:10.1074/jbc.274.43.30799.

Monk SA, Desai K, Brady CA, Williams JM, Lin L, Princivalle A, Hope AG, Barnes NM (2001). «Generation of a selective 5-HT_3B subunit-recognising polyclonal antibody; identification of immunoreactive cells in rat hippocampus». Neuropharmacology 41 (8): 1013-1016. PMID 11747906. doi:10.1016/S0028-3908(01)00153-8.

Boyd GW, Low P, Dunlop JI, Ward M, Vardy AW, Lambert JJ, Peters J, Conolly CN (2002). «Assembly and cell surface expression of homomeric and heteromeric 5-HT3 receptors: The role of oligomerisation and chaperone proteins». Mol Cell Neurosci 21 (1): 38-50. PMID 12359150. doi:10.1006/mcne.2002.1160.

Niesler B, Walstab J, Combrink S, Moeller D, Kapeller J, Rietdorf J, Boenisch H, Goethert M, Rappold G, Bruess M (2007). «Characterization of the Novel Human Serotonin Receptor Subunits 5-HT_3C, 5- HT_3D and 5-HT_3E». Mol Pharmacol 72 (Mar 28): 8-17. PMID 17392525. doi:10.1124/mol.106.032144.

Niesler, Beate (February 2011). «5-HT₃ receptors: potential of individual isoforms for personalised therapy». Current Opinion in Pharmacology 11 (1): 81-86. PMID 21345729. doi:10.1016/j.coph.2011.01.011.

Quirk, Phillip L.; Rao, Suma; Roth, Bryan L.; Siegel, Ruth E. (15 de agosto de 2004). «Three putative N-glycosylation sites within the murine 5-HT3A receptor sequence affect plasma membrane targeting, ligand binding, and calcium influx in heterologous mammalian cells». Journal of Neuroscience Research 77 (4): 498-506. ISSN 0360-4012. PMID 15264219. doi:10.1002/jnr.20185.

Sanger GJ (September 2008). «5-hydroxytryptamine and the gastrointestinal tract: where next?». Trends in Pharmacological Sciences 29 (9): 465-471. PMID 19086255. doi:10.1016/j.tips.2008.06.008.

Uetz, P; Abdelatty, F; Villarroel, A; Rappold, G; Weiss, B; Koenen, M (1994). «Organisation of the murine 5-HT3 receptor gene and assignment to human chromosome 11». FEBS Letters 339 (3): 302-306. PMID 8112471. doi:10.1016/0014-5793(94)80435-4.

Férézou I, Cauli B, Hill EL, Rossier J, Hamel E, Lambolez B (2002). «5-HT₃ receptors mediate serotonergic fast synaptic excitation of neocortical vasoactive intestinal peptide/cholecystokinin interneurons». J Neurosci 22 (17): 7389-7397. PMC 6757992. PMID 12196560. doi:10.1523/JNEUROSCI.22-17-07389.2002.

Kazuyoshi Kawa (1994). «Distribution and Functional Properties of 5HT₃ Receptors in the Rat Hippocampus Dentate Gyrus». Journal of Neurophysiology 71 (5): 1935-1947. PMID 7520482. doi:10.1152/jn.1994.71.5.1935.

Sugita S, Shen KZ, North RA (1992). «5-hydroxytryptamine is a fast excitatory transmitter at 5-HT₃ receptors in rat amygdala». Neuron 8 (1): 199-203. PMID 1346089. doi:10.1016/0896-6273(92)90121-S.

Rondé P, Nichols RA (1998). «High calcium permeability of serotonin 5-HT₃ receptors on presynaptic nerve terminals from rat striatum». J Neurochem 70 (3): 1094-1103. PMID 9489730. doi:10.1046/j.1471-4159.1998.70031094.x.

Rondé P, Nichols RA (1997). «5-HT₃ receptors induce rises in cytosolic and nuclear calcium in NG108-15 cells via calcium-induced calcium release». Cell Calcium 22 (5): 357-365. PMID 9448942. doi:10.1016/S0143-4160(97)90020-8.

van Hooft JA, Vijverberg HP (2000). «5-HT₃ receptors and neurotransmitter release in the CNS: a nerve ending story?». Trends Neurosci 23 (12): 605-610. PMID 11137150. doi:10.1016/S0166-2236(00)01662-3.

Gholipour T, Ghasemi M, Riazi K, Ghaffarpour M, Dehpour AR (January 2010). «Seizure susceptibility alteration through 5-HT(3) receptor: modulation by nitric oxide». Seizure 19 (1): 17-22. PMID 19942458. doi:10.1016/j.seizure.2009.10.006.

Patel, Ryan; Dickenson, Anthony H. (September 2018). «Modality selective roles of pro-nociceptive spinal 5-HT2A and 5-HT3 receptors in normal and neuropathic states». Neuropharmacology 143: 29-37. ISSN 0028-3908. PMC 6277848. PMID 30240783. doi:10.1016/j.neuropharm.2018.09.028.

Suzuki, Rie; Rahman, Wahida; Rygh, Lars J; Webber, Mark; Hunt, Stephen P; Dickenson, Anthony H (October 2005). «Spinal-supraspinal serotonergic circuits regulating neuropathic pain and its treatment with gabapentin». Pain 117 (3): 292-303. ISSN 0304-3959. PMID 16150546. doi:10.1016/j.pain.2005.06.015.

Mineur YS, Picciotto MR (December 2010). «Nicotine receptors and depression: revisiting and revising the cholinergic hypothesis». Trends Pharmacol. Sci. 31 (12): 580-586. PMC 2991594. PMID 20965579. doi:10.1016/j.tips.2010.09.004.

Imanishi, N.; Iwaoka, K.; Koshio, H.; Nagashima, S. Y.; Kazuta, K. I.; Ohta, M.; Sakamoto, S.; Ito, H. et al. (2003). «New thiazole derivatives as potent and selective 5-hydroxytriptamine 3 (5-HT3) receptor agonists for the treatment of constipation». Bioorganic & Medicinal Chemistry 11 (7): 1493-1502. PMID 12628674. doi:10.1016/S0968-0896(02)00557-6. Se sugiere usar |número-autores= (ayuda)

Delagrange, Philippe; Emerit, M.Boris; Merahi, Nacera; Abraham, Christine; Morain, Philippe; Rault, Sylvain; Renard, Pierre; Pfeiffer, Bruno et al. (1996). «Interaction of S 21007 with 5-HT3 receptors. In vitro and in vivo characterization». European Journal of Pharmacology 316 (2–3): 195-203. ISSN 0014-2999. PMID 8982686. doi:10.1016/S0014-2999(96)00680-2. Se sugiere usar |número-autores= (ayuda)

Ashoor, A.; Nordman, J.; Veltri, D.; Susan Yang, K. -H.; Shuba, Y.; Al Kury, L.; Sadek, B.; Howarth, F. C. et al. (2013). «Menthol Inhibits 5-Ht3 Receptor-Mediated Currents». Journal of Pharmacology and Experimental Therapeutics 347 (2): 398-409. PMID 23965380. doi:10.1124/jpet.113.203976. Se sugiere usar |número-autores= (ayuda)

Newman, A. S.; Batis, N; Grafton, G; Caputo, F; Brady, C. A.; Lambert, J. J.; Peters, J. A.; Gordon, J et al. (2013). «5-Chloroindole: A potent allosteric modulator of the 5-HT3 receptor». British Journal of Pharmacology 169 (6): 1228-1238. PMC 3831704. PMID 23594147. doi:10.1111/bph.12213. Se sugiere usar |número-autores= (ayuda)

Davies, Paul A (2011). «Allosteric modulation of the 5-HT3 receptor». Current Opinion in Pharmacology (Elsevier BV) 11 (1): 75-80. ISSN 1471-4892. PMC 3072441. doi:10.1016/j.coph.2011.01.010.

Solt, Ken; Stevens, Renna J.; Davies, Paul A.; Raines, Douglas E. (4 de agosto de 2005). «General Anesthetic-Induced Channel Gating Enhancement of 5-Hydroxytryptamine Type 3 Receptors Depends on Receptor Subunit Composition». Journal of Pharmacology and Experimental Therapeutics (American Society for Pharmacology & Experimental Therapeutics (ASPET)) 315 (2): 771-776. ISSN 0022-3565. doi:10.1124/jpet.105.090621.

Thompson AJ, Lummis SC (2007). «The 5-HT3 receptor as a therapeutic target». Expert Opin Ther Targets 11 (4): 527-540. PMC 1994432. PMID 17373882. doi:10.1517/14728222.11.4.527.

issn.org

portal.issn.org

Davies, Paul A (2011). «Allosteric modulation of the 5-HT3 receptor». Current Opinion in Pharmacology (Elsevier BV) 11 (1): 75-80. ISSN 1471-4892. PMC 3072441. doi:10.1016/j.coph.2011.01.010.

nih.gov

ncbi.nlm.nih.gov

Thompson AJ, Lummis SC (2006). «5-HT3 Receptors». Current Pharmaceutical Design 12 (28): 3615-3630. PMC 2664614. PMID 17073663. doi:10.2174/138161206778522029.

Sanger GJ (September 2008). «5-hydroxytryptamine and the gastrointestinal tract: where next?». Trends in Pharmacological Sciences 29 (9): 465-471. PMID 19086255. doi:10.1016/j.tips.2008.06.008.

Roerig B, Nelson DA, Katz LC (1992). «Fast synaptic signaling by nicotinic acetylcholine and serotonin 5-HT₃ receptors in developing visual cortex». J Neurosci 17 (21): 199-203. PMC 6573745. PMID 9334409.

Davies, Paul A (2011). «Allosteric modulation of the 5-HT3 receptor». Current Opinion in Pharmacology (Elsevier BV) 11 (1): 75-80. ISSN 1471-4892. PMC 3072441. doi:10.1016/j.coph.2011.01.010.

Thompson AJ, Lummis SC (2007). «The 5-HT3 receptor as a therapeutic target». Expert Opin Ther Targets 11 (4): 527-540. PMC 1994432. PMID 17373882. doi:10.1517/14728222.11.4.527.

Receptor 5-HT3 (Spanish Wikipedia)

archive.org

doi.org

dx.doi.org

harvard.edu

adsabs.harvard.edu

issn.org

portal.issn.org

nih.gov

ncbi.nlm.nih.gov